Header Logo

Connection

MIGUEL CRUZ to von Willebrand Factor

Back to Details
This is a "connection" page, showing publications MIGUEL CRUZ has written about von Willebrand Factor.
MIGUEL CRUZ
Connection Strength
7.605
von Willebrand Factor
  1. The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma. Blood Coagul Fibrinolysis. 2024 Jul 01; 35(5):256-264.
    View in: PubMed
    Score: 0.775
  2. Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices. Blood. 2015 Nov 12; 126(20):2338-41.
    View in: PubMed
    Score: 0.423
  3. A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia. Thromb Res. 2015 May; 135(5):1025-30.
    View in: PubMed
    Score: 0.409
  4. Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress. Blood. 2014 Apr 24; 123(17):2715-21.
    View in: PubMed
    Score: 0.383
  5. N-terminal flanking region of A1 domain in von Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress. J Biol Chem. 2012 Apr 27; 287(18):14579-85.
    View in: PubMed
    Score: 0.334
  6. The mechanism of VWF-mediated platelet GPIbalpha binding. Biophys J. 2010 Aug 09; 99(4):1192-201.
    View in: PubMed
    Score: 0.298
  7. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha. J Thromb Haemost. 2007 Jul; 5(7):1363-70.
    View in: PubMed
    Score: 0.236
  8. The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen. J Thromb Haemost. 2006 Feb; 4(2):417-25.
    View in: PubMed
    Score: 0.218
  9. The platelet glycoprotein Ib-von Willebrand factor interaction activates the collagen receptor alpha2beta1 to bind collagen: activation-dependent conformational change of the alpha2-I domain. Blood. 2005 Mar 01; 105(5):1986-91.
    View in: PubMed
    Score: 0.200
  10. Variations among normal individuals in the cleavage of endothelial-derived ultra-large von Willebrand factor under flow. J Thromb Haemost. 2004 Aug; 2(8):1460-6.
    View in: PubMed
    Score: 0.197
  11. The effect of ADAMTS13 on graft-versus-host disease. J Cell Mol Med. 2024 Jul; 28(13):e18457.
    View in: PubMed
    Score: 0.195
  12. ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate. J Thromb Haemost. 2004 Mar; 2(3):485-91.
    View in: PubMed
    Score: 0.191
  13. Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate. Thromb Haemost. 2003 Dec; 90(6):1204-9.
    View in: PubMed
    Score: 0.188
  14. Force-induced biphasic regulation of VWF cleavage by ADAMTS13. Thromb Res. 2023 09; 229:99-106.
    View in: PubMed
    Score: 0.182
  15. Platelet aggregation by membrane-expressed A1 domains of von Willebrand Factor is dependent on residues Asp 560 and Gly 561. Biochem Biophys Res Commun. 2003 Mar 21; 302(4):873-7.
    View in: PubMed
    Score: 0.179
  16. Conformation-dependent blockage of activated VWF improves outcomes of traumatic brain injury in mice. Blood. 2021 01 28; 137(4):544-555.
    View in: PubMed
    Score: 0.154
  17. Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:1076029621992128.
    View in: PubMed
    Score: 0.153
  18. Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain. J Biol Chem. 2000 Jun 23; 275(25):19098-105.
    View in: PubMed
    Score: 0.148
  19. Modulating the rate of fibrin formation and clot structure attenuates microvascular thrombosis in systemic inflammation. Blood Adv. 2020 04 14; 4(7):1340-1349.
    View in: PubMed
    Score: 0.146
  20. Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease. J Mol Biol. 2020 01 17; 432(2):305-323.
    View in: PubMed
    Score: 0.141
  21. Domain-specific mechanical modulation of VWF-ADAMTS13 interaction. Mol Biol Cell. 2019 07 22; 30(16):1920-1929.
    View in: PubMed
    Score: 0.137
  22. In vitro phosphorylation of von Willebrand factor by FAM20c enhances its ability to support platelet adhesion. J Thromb Haemost. 2019 06; 17(6):866-877.
    View in: PubMed
    Score: 0.136
  23. Extracellular Vimentin/VWF (von Willebrand Factor) Interaction Contributes to VWF String Formation and Stroke Pathology. Stroke. 2018 10; 49(10):2536-2540.
    View in: PubMed
    Score: 0.131
  24. Quantification of Von Willebrand Factor Cleavage by adamts-13 in Patients Supported by Left Ventricular Assist Devices. ASAIO J. 2017 Nov/Dec; 63(6):849-853.
    View in: PubMed
    Score: 0.123
  25. Disruption of protein complexes containing protein phosphatase?2B and Munc18c reduces the secretion of von Willebrand factor from endothelial cells. J Thromb Haemost. 2017 05; 15(5):1032-1039.
    View in: PubMed
    Score: 0.118
  26. Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides. J Biol Chem. 1995 May 05; 270(18):10822-7.
    View in: PubMed
    Score: 0.104
  27. The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein. J Biol Chem. 1993 Oct 05; 268(28):21238-45.
    View in: PubMed
    Score: 0.093
  28. Interaction of Shiga toxin with the A-domains and multimers of von Willebrand Factor. J Biol Chem. 2013 Nov 15; 288(46):33118-23.
    View in: PubMed
    Score: 0.093
  29. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Iba. J Biol Chem. 2013 Nov 08; 288(45):32289-32301.
    View in: PubMed
    Score: 0.093
  30. The interaction between factor H and Von Willebrand factor. PLoS One. 2013; 8(8):e73715.
    View in: PubMed
    Score: 0.092
  31. The linker between the D3 and A1 domains of vWF suppresses A1-GPIba catch bonds by site-specific binding to the A1 domain. Protein Sci. 2013 Aug; 22(8):1049-59.
    View in: PubMed
    Score: 0.092
  32. Functional analysis of a recombinant glycoprotein Ib alpha polypeptide which inhibits von Willebrand factor binding to the platelet glycoprotein Ib-IX complex and to collagen. J Biol Chem. 1992 Jan 15; 267(2):1303-9.
    View in: PubMed
    Score: 0.082
  33. GPIba-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease. Biophys J. 2011 Jan 19; 100(2):304-12.
    View in: PubMed
    Score: 0.077
  34. Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress. J Biol Chem. 2010 Jul 23; 285(30):22831-9.
    View in: PubMed
    Score: 0.074
  35. Force-induced cleavage of single VWFA1A2A3 tridomains by ADAMTS-13. Blood. 2010 Jan 14; 115(2):370-8.
    View in: PubMed
    Score: 0.071
  36. Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha. Biophys J. 2009 Jul 22; 97(2):618-27.
    View in: PubMed
    Score: 0.069
  37. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thromb Haemost. 2009 Jun; 101(6):1070-7.
    View in: PubMed
    Score: 0.069
  38. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest. 2008 Sep; 118(9):3195-207.
    View in: PubMed
    Score: 0.065
  39. Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions. Thromb Haemost. 2008 Mar; 99(3):586-93.
    View in: PubMed
    Score: 0.063
  40. Conformational stability and domain unfolding of the Von Willebrand factor A domains. J Mol Biol. 2007 Feb 23; 366(3):986-1000.
    View in: PubMed
    Score: 0.057
  41. C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood. 2006 Jan 15; 107(2):423-30.
    View in: PubMed
    Score: 0.053
  42. Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor. Biophys J. 2005 Jun; 88(6):4391-401.
    View in: PubMed
    Score: 0.051
  43. The alpha1 helix-beta13 strand spanning Leu214 to Val229 of platelet glycoprotein Ibalpha facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1. Blood. 2004 Dec 15; 104(13):3971-8.
    View in: PubMed
    Score: 0.049
  44. Von Willebrand factor present in fibrillar collagen enhances platelet adhesion to collagen and collagen-induced platelet aggregation. J Thromb Haemost. 2004 Apr; 2(4):660-9.
    View in: PubMed
    Score: 0.048
  45. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates. Biophys J. 2003 Dec; 85(6):4099-109.
    View in: PubMed
    Score: 0.047
  46. Glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3): effects of receptor clustering and von Willebrand factor adhesion. J Thromb Haemost. 2003 Jun; 1(6):1150-7.
    View in: PubMed
    Score: 0.045
  47. Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood. J Thromb Haemost. 2003 Jun; 1(6):1288-95.
    View in: PubMed
    Score: 0.045
  48. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor. J Biol Chem. 2003 Aug 08; 278(32):29633-9.
    View in: PubMed
    Score: 0.045
  49. High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19. J Thromb Thrombolysis. 2022 Aug; 54(2):211-216.
    View in: PubMed
    Score: 0.043
  50. Structural basis of von Willebrand factor activation by the snake toxin botrocetin. Structure. 2002 Jul; 10(7):943-50.
    View in: PubMed
    Score: 0.043
  51. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood. 2002 Jun 01; 99(11):3971-7.
    View in: PubMed
    Score: 0.042
  52. Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor. Blood. 1997 Dec 01; 90(11):4425-37.
    View in: PubMed
    Score: 0.031
  53. Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury. Crit Care Clin. 2015 Oct; 31(4):661-74.
    View in: PubMed
    Score: 0.026
  54. Glycoprotein Ib can mediate endothelial cell attachment to a von Willebrand factor substratum. Thromb Haemost. 1995 Feb; 73(2):309-17.
    View in: PubMed
    Score: 0.025
  55. Reconstitution of the platelet glycoprotein Ib-IX complex in phospholipid bilayer Nanodiscs. Biochemistry. 2011 Dec 13; 50(49):10598-606.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.